BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit


Werte in diesem Artikel
Aktien

3.98 EUR -0.06 EUR -1.58 %

LOS ANGELES, Sept. 14, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Bausch Health Companies Inc. ("Bausch" or the "Company") (NYSE: BHC).

Class Period: August 6, 2020May 3, 2023
Lead Plaintiff Deadline:September 25, 2023

If you are a shareholder who suffered a loss, click here to participate.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) the B+L spinoff would not result in two strong separate companies; (2) without B+L, Bausch was left overly leveraged and without the cashflow generated by B+L; (3) distribution of the B+L spinoff shares would not occur as represented; (4) the above statements omitted and/or concealed the potential damages Bausch faced from the Opt-Out Plaintiffs; (5) the spinoff was not intended to benefit Bausch shareholders but instead designed to subvert the Opt-Out Plaintiffs' lawsuit against the company; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.  If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com.  If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Cision View original content:https://www.prnewswire.com/news-releases/bhc-investors-have-opportunity-to-lead-bausch-health-companies-inc-securities-fraud-lawsuit-301928328.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

Aktuelle Bausch Health Aktie News

Werbung

Bausch Health Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Bausch Health nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
19.07.19 Bausch Health Outperform Wolfe Research
11.06.19 Bausch Health Overweight Barclays Capital
06.04.18 Valeant Pharmaceuticals International Neutral Mizuho
16.01.18 Valeant Pharmaceuticals International Buy H.C. Wainwright & Co.
15.12.17 Valeant Pharmaceuticals International Underperform Mizuho